✦ LIBER ✦

Cost-effectiveness analysis of drug-eluting stents in Australia from the Melbourne Interventional Group Registry

✍ Scribed by Bryan P. Yan; Angela Brennan; Molla Huq; Nick Andrianopolous; Andrew E. Ajani; David Clark; Christopher M. Reid

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Drug Eluting Stents in Long but L

✍ M. Rahman; D. Clark; T. Yip; A. Black; N. Andrianopoulos; A. Brennan; A.E. Ajani 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Gender differences in percutaneous coron

✍ J. Sapontis; S.L. Ching; M.J. Moore; W. Childs; L. Roberts; A. Brennan; N. Adria 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Clinical Outcome of Percutaneous Coronar

✍ William Chan; Andrew E. Ajani; David J. Clark; Nick Andrianopoulos; Michelle J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Validation of the Mayo Clinic Risk Score

✍ Bryan P. Yan; Nick Andrianopoulos; Thomas J. Kiernan; Andrew E. Ajani; David J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 73 KB

PCV47 A COST-EFFECTIVENESS ANALYSIS OF T

✍ A Wenk-Lang; C Knight 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

IMPROVED OUTCOMES WITH DRUG ELUTING VERS

✍ Tolerico, Paul H.; Cohen, David J.; Kleiman, Neal S.; Berger, Peter B.; Brilakis 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 119 KB